STOCK TITAN

Lantheus (LNTH) Form 144 Shows 3,060-Share Sale Planned on NASDAQ

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Form 144 filed for Lantheus Holdings, Inc (LNTH) discloses an intended sale of 3,060 common shares through Fidelity Brokerage with an aggregate market value of $163,924.20. The filing lists the approximate sale date as 08/13/2025 and identifies the securities exchange as NASDAQ. The shares to be sold were acquired through company programs: 221 shares via an ESPP purchase on 03/13/2023 (paid in cash) and 2,839 shares from restricted stock vesting on 03/02/2024, 03/03/2024, and 04/17/2024 as compensation.

The filing also reports a prior sale by Paul Blanchfield of 6,599 common shares on 06/05/2025 for gross proceeds of $525,610.35. Certain filer identification fields appear blank in the provided content. The document includes the standard seller representation that they have no undisclosed material adverse information.

Positive

  • Acquisition sources disclosed: Shares being sold were acquired via ESPP and restricted stock vesting, which are standard compensation channels.
  • Full transaction details provided: Number of shares, acquisition dates, payment nature, broker, and planned sale date are all listed.

Negative

  • Recent prior sale disclosed: Paul Blanchfield sold 6,599 shares on 06/05/2025 for $525,610.35.
  • Filer identification incomplete: The provided extract shows empty filer identifier fields (CIK/CCC not populated).

Insights

TL;DR: Routine insider sale notice showing 3,060 shares from compensation sources; prior June sale of 6,599 shares.

The filing documents an intended sale under Rule 144 of 3,060 common shares valued at $163,924.20, scheduled for 08/13/2025 on NASDAQ via Fidelity. The shares were acquired through an ESPP and restricted stock vesting between 03/13/2023 and 04/17/2024, indicating these holdings originated from compensation rather than open-market purchases. The filing also discloses a recent sale of 6,599 shares on 06/05/2025 for $525,610.35, which is material for tracking insider liquidity but is a routine disclosure without additional context in this document.

TL;DR: Disclosure is procedural under Rule 144; acquisition dates and transaction types are clearly listed, but filer identifiers are incomplete.

The notice provides required acquisition details showing the 3,060 shares derive from an ESPP purchase and several restricted stock vesting events, with payment methods recorded as cash and compensation. This transparency supports compliance with Rule 144 requirements. However, the filing content supplied here has missing filer identification details (CIK/CCC not populated), limiting verifiability solely from this extract. The standard signature representation regarding absence of undisclosed material information is included.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the LNTH Form 144 disclose about planned insider sales?

The Form 144 shows a planned sale of 3,060 common shares valued at $163,924.20, to be sold via Fidelity on NASDAQ on 08/13/2025.

How were the shares that are being sold acquired according to the filing?

The filing lists acquisition sources as an ESPP purchase of 221 shares on 03/13/2023 (cash) and restricted stock vesting totaling 2,839 shares on 03/02/2024, 03/03/2024, and 04/17/2024 (compensation).

Did the filer recently sell any shares of LNTH?

Yes, the document reports that Paul Blanchfield sold 6,599 common shares on 06/05/2025 for gross proceeds of $525,610.35.

Which broker and exchange are involved in the planned sale?

The planned sale is through Fidelity Brokerage Services LLC and the securities are listed for sale on NASDAQ.

Does the filing include the seller's representation about material nonpublic information?

Yes, the filing includes the standard representation that the seller does not know any material adverse information about the issuer that has not been publicly disclosed.
Lantheus Holding

NASDAQ:LNTH

LNTH Rankings

LNTH Latest News

LNTH Latest SEC Filings

LNTH Stock Data

4.56B
64.72M
2.24%
117.27%
11.08%
Drug Manufacturers - Specialty & Generic
In Vitro & in Vivo Diagnostic Substances
Link
United States
NORTH BILLERICA